Anti-TAGLN/Transgelin 抗体
Anti-TAGLN/Transgelin antibody
5
(27 Reviews)
|
(536 Publications)
Anti-TAGLN/Transgelin antibody (ab14106) is a rabbit polyclonal antibody detecting TAGLN/Transgelin in Western Blot, ICC/IF. Suitable for Human, Mouse, Rat.
- Over 430 publications
- Trusted since 2005
別名を表示する
Sm22, Sm22a, Transgelin, Actin-associated protein p27, Smooth muscle protein 22-alpha, SM22-alpha
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-TAGLN/Transgelin antibody (AB14106)
ab14106 stained HeLa (Human epithelial cell line from cervix adenocarcinoma) cells.
The cells were fixed in 100% methanol for 5 minutes, permeabilized in 0.1% PBS-Triton X-100 for 5 minutes and then incubated in 1% BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1 hour at room temperature to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab14106 at 1 μg/ml) overnight at +4°C. The secondary antibody (pseudo-colored green) was ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed used at a 1/1000 dilution for 1 hour at room temperature. Alexa Fluor® 594 WGA was used to label plasma membranes (pseudo-colored red) at a 1/200 dilution for 1 hour at room temperature.
DAPI was used to stain the cell nuclei (pseudo-colored blue) at a concentration of 1.43μM for 1 hour at room temperature.
- ICC/IF
AbReview42536****
Immunocytochemistry/ Immunofluorescence - Anti-TAGLN/Transgelin antibody (AB14106)
ab14106 staining SM22 alpha in mouse muscle cells by ICC/IF (Immunocytochemistry/immunofluorescence).
Cells were fixed with paraformaldehyde, permeabilized with 0.1% Triton X-100 and blocked with 10% serum for 30 minutes at 25°C. Samples were incubated with primary antibody (1/100 in PBS) for 18 hours at 4°C. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG polyclonal was used as the secondary antibody at a dilution of 1/1000.
This image is courtesy of an anonymous Abreview.
- WB
Ap
Western blot - Anti-TAGLN/Transgelin antibody (AB14106)
This blot was produced using a 4-12% Bis-tris gel under the MES buffer system. The gel was run at 200V for 35 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab14106 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution ab133406.
All lanes:
Western blot - Anti-TAGLN/Transgelin antibody (ab14106) at 1 µg/mL
Lane 1:
Human colon tissue lysate - total protein (ab30051) at 10 µg
Lane 2:
Mouse colon tissue lysate at 10 µg
Lane 3:
Rat colon tissue lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG H&L (HRP) preadsorbed at 1/50000 dilution
Predicted band size: 23 kDa
Observed band size: 115 kDa,20 kDa,23 kDa,36 kDa
true
Exposure time: 5s
- WB
Unknown
Western blot - Anti-TAGLN/Transgelin antibody (AB14106)
The band was completed abolished by peptide blocking with ab16067 (immunizing peptide) - not shown.
All lanes:
Western blot - Anti-TAGLN/Transgelin antibody (ab14106) at 1 µg/mL
Lane 1:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
HeLa nuclear extract at 20 µg
Lane 3:
Human skeletal muscle tissue lysate at 20 µg
Secondary
All lanes:
Alexa Fluor Goat polyclonal to Rabbit IgG at 1/10000 dilution
Predicted band size: 23 kDa
Observed band size: 23 kDa
false
- WB
Unknown
Western blot - Anti-TAGLN/Transgelin antibody (AB14106)
All lanes:
Western blot - Anti-TAGLN/Transgelin antibody (ab14106) at 1 µg/mL
Lane 1:
Western blot - Recombinant Human TAGLN/Transgelin protein (His tag N-Terminus) (<a href='/products/proteins-peptides/recombinant-human-tagln-transgelin-protein-ab101469'>ab101469</a>) at 0.01 µg
Lane 1:
Western blot - Recombinant Human SPG21/Maspardin protein (His tag N-Terminus) (<a href='/products/proteins-peptides/recombinant-human-spg21-maspardin-protein-ab86438'>ab86438</a>)
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-preadsorbed-ab97080'>ab97080</a>) at 1/5000 dilution
Predicted band size: 23 kDa,35 kDa
true
Exposure time: 30s
- WB
AbReview16283****
Western blot - Anti-TAGLN/Transgelin antibody (AB14106)
All lanes:
Western blot - Anti-TAGLN/Transgelin antibody (ab14106) at 1/1000 dilution
All lanes:
Lysates prepared from human primary smooth muscle cells at 30 µg
Secondary
All lanes:
HRP-conjugated bovine polyclonal to rabbit IgG at 1/2000 dilution
Predicted band size: 23 kDa
Observed band size: 23 kDa
true
Exposure time: 2min
This image is a courtesy of Anonymous Abreview
- WB
CiteAb
Western blot - Anti-TAGLN/Transgelin antibody (AB14106)
Western Blotting using Anti-TAGLN/Transgelin antibody, ab14106. Publication image from Boehm, M. et al., 2016, Nat Commun, 27340017. Legend direct from paper.
Hypoxia increases EndMT and is additive to the effect of TGF-β.(a) Representative pimonidazole staining demonstrating the extent of hypoxia in aortic sections from tamoxifen-induced end.SclCreERT;R26RstopYfp;ApoE−/− mice fed 8 versus 18 weeks HFD. Staining in red is indicative of hypoxia with pO2 <10 mm Hg. Specific staining was performed using pimonidazole (seen in red) and DAPI (blue). L=lumen; scale bars, 100 µm. Staining was performed on at least three spatially separated thoracic aortic sections per mouse (n=5 mice per group). Analysis by one-way ANOVA; overall P<0.0001. (b) Immunostaining of HCAECs exposed to hypoxia and/or TGF-β for 5 days in vitro. Scale bars, 100 µm. (c–f) Relative RNA expression of mesenchymal genes FAP, SM22α, Calponin and Versican (respectively) in HCAECs was increased by hypoxia as assessed by qRT-PCR. (g–j) Relative RNA expression of endothelial genes CD31, Ve-Cadherin, eNOS and KDR assessed by qRT-PCR showed mixed effects in response to hypoxia. (k–l) Relative RNA expression of SNAI2 and SNAI1 in HCAECs was increased by hypoxia. (m) SM22α protein expression, assessed by western blot in HCAECs, was increased by hypoxia as indicated. SM22α ladder (L) represents 25 kDa (upper), 20 kDa (middle) and 15 kDa (lower). SM22α expected molecular weight/size is 23 kDa. GAPDH ladder represents 37 kDa. GAPDH expected molecular weight/size is 37 kDa. (n) CD31 protein expression, assessed by western blot in HCAECs. CD31 ladder (L) represents 150 kDa. CD31 expected molecular weight/size is 130 kDa. GAPDH ladder represents 37 kDa. GAPDH expected molecular weight/size is 37 kDa. As our intent was to evaluate the specific effect of hypoxia, and not interactions with TGF-β (which is provided as a reference), t testing was performed in this case. n=3 in all experiments. All experiments replicated >3 times. NS, not significant, *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.
false
Reactivity data
製品の詳細
Anti-TAGLN/Transgelin antibody (ab14106) is a rabbit polyclonal antibody and is validated for use in ICC/IF, WB in human, mouse, rat samples.
Quality and Validation
Anti-TAGLN/Transgelin antibody (ab14106) specifically detects TAGLN/Transgelin (UniProt ID: Q01995; Molecular weight: 22kDa) and is sold in 100 µg selling sizes.
Abcam's high quality validation processes ensure Anti-TAGLN/Transgelin antibody (ab14106) has high sensitivity and specificity.
Anti-TAGLN/Transgelin antibody (ab14106) has been cited over 435 times in peer reviewed journals and is trusted by the scientific community.
Anti-TAGLN/Transgelin antibody (ab14106) has 27 independent reviews from customers.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The regulatory involvement of TAGLN in smooth muscle contraction influences cellular activities essential for vascular function. This protein modulates remodeling and differentiation within smooth muscle cells. It can associate with actin and calponin to form complexes that regulate the stability of cytoskeletal structures ensuring effective cellular responses to mechanical stimuli. By linking signal transduction to cytoskeletal mechanics TAGLN facilitates the maintenance of cell shape and tension.
Pathways
TAGLN plays a role in the regulation of the RhoA/Rho kinase pathway contributing to actin cytoskeleton organization and smooth muscle contraction. Additionally it is involved in the WNT signaling pathway influencing cell proliferation and differentiation. In these pathways TAGLN works with proteins like RhoA and beta-catenin to transmit signals from the extracellular environment to the nucleus impacting gene expression and cellular responses.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
文献 (536)
Recent publications for all applications. Explore the full list and refine your search
Cell death & disease 16:678 PubMed41053113
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 55:257-270 PubMed41050141
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell communication and signaling 19:e70048 PubMed41040887
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biomedical science 32:78 PubMed40836335
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature neuroscience 28:1868-1882 PubMed40796665
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:24657 PubMed40634394
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:6232 PubMed40623996
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:6241 PubMed40624080
2025
Applications
Unspecified application
Species
Unspecified reactive species
eLife 13: PubMed40622747
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bio-protocol 15:e5355 PubMed40620805
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com